Showing results (101-110 of 370) with videos related to

Sort By:
Pageof 37
The Journal of Clinical Endocrinology and Metabolism|September 2, 2016
Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case ReportNaris Nilubol, Esther M Freedman, Martha M Quezado, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 2011
Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposingLisa Zhang, Mei He, Yaqin Zhang, et al.
Annals of Surgical Oncology|November 15, 2017
Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective AnalysisApostolos Gaitanidis, Dhaval Patel, Naris Nilubol, et al.
Gastroenterology|November 21, 2017
Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine TumorsAmit Tirosh, Georgios Z Papadakis, Corina Millo, et al.
Cancer|April 8, 2011
MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancyErin E Patterson, Alisha K Holloway, Julie Weng, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|April 9, 2020
Surgery for adrenocortical carcinoma: When and how?Tiffany J Sinclair, Andrea Gillis, Wilson M Alobuia, et al.
Experimental Dermatology|June 5, 2009
Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancerJürgen Bauer, Julie Weng, Electron Kebebew, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 23, 2006
Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive casesWen T Shen, James Lee, Electron Kebebew, et al.
Journal of Surgical Oncology|November 17, 2019
Preoperative systemic inflammatory markers are prognostic indicators in recurrent adrenocortical carcinomaApostolos Gaitanidis, Douglas Wiseman, Mustapha El Lakis, et al.
Pageof 37